UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Partial Histological Tumor Regression in Primary Melanoma as Protective Factor for Lymph Node Micrometastasis

JAMA dermatology (Chicago, Ill.), 2015-12, Vol.151 (12), p.1291

Garbe, Claus

2015

Volltextzugriff (PDF)

Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelines

European journal of cancer (1990), 2019-09, Vol.118, p.10-34

2019

Volltextzugriff (PDF)

Melanoma epidemiology and trends

Clinics in dermatology, 2009, Vol.27 (1), p.3-9

2009

Volltextzugriff (PDF)

Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma

The New England journal of medicine, 2011-06, Vol.364 (26), p.2517-2526

2011

Volltextzugriff (PDF)

European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics – Update 2019

European journal of cancer (1990), 2020-02, Vol.126, p.141-158

2020

Volltextzugriff (PDF)

Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

The New England journal of medicine, 2011-06, Vol.364 (26), p.2507-2516

2011

Volltextzugriff (PDF)

Phase II DeCOG-study of ipilimumab in pretreated and treatment-naïve patients with metastatic uveal melanoma

PloS one, 2015-03, Vol.10 (3), p.e0118564

2015

Volltextzugriff (PDF)

Phase III Randomized Clinical Trial Comparing Tremelimumab With Standard-of-Care Chemotherapy in Patients With Advanced Melanoma

Journal of clinical oncology, 2013-02, Vol.31 (5), p.616-622

2013

Volltextzugriff (PDF)

Improving melanoma classification by integrating genetic and morphologic features

PLoS medicine, 2008-06, Vol.5 (6), p.e120-e120

2008

Volltextzugriff (PDF)

Final Results of Phase III SYMMETRY Study: Randomized, Double-Blind Trial of Elesclomol Plus Paclitaxel Versus Paclitaxel Alone As Treatment for Chemotherapy-Naive Patients With Advanced Melanoma

Journal of clinical oncology, 2013-03, Vol.31 (9), p.1211-1218

2013

Volltextzugriff (PDF)

Results of a Phase III, Randomized, Placebo-Controlled Study of Sorafenib in Combination With Carboplatin and Paclitaxel As Second-Line Treatment in Patients With Unresectable Stage III or Stage IV Melanoma

Journal of clinical oncology, 2009-06, Vol.27 (17), p.2823-2830

2009

Volltextzugriff (PDF)

Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients

Journal of immunotherapy, 2009-06, Vol.32 (5), p.498-507

2009

Volltextzugriff (PDF)

β-Catenin signaling increases during melanoma progression and promotes tumor cell survival and chemoresistance

PloS one, 2011, Vol.6 (8), p.e23429

2011

Volltextzugriff (PDF)

Real-world Treatment Patterns and Outcomes with Systemic Therapies in Unresectable Locally Advanced and Metastatic Cutaneous Squamous Cell Carcinoma in Germany

Acta dermato-venereologica, 2022-01, Vol.102, p.adv00637-adv00637

2022

Volltextzugriff (PDF)

Peripheral PD-1+CD56+ T-cell frequencies correlate with outcome in stage IV melanoma under PD-1 blockade

PloS one, 2019-08, Vol.14 (8), p.e0221301-e0221301

2019

Volltextzugriff (PDF)

Diagnostic Accuracy of Electrical Impedance Spectroscopy in Non-melanoma Skin Cancer

Acta dermato-venereologica, 2020-11, Vol.100 (18), p.adv00328-adv00328

2020

Volltextzugriff (PDF)

Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies

Journal for immunotherapy of cancer, 2019-12, Vol.7 (1), p.343-343, Article 343

2019

Volltextzugriff (PDF)

Functional T Cells Targeting NY-ESO-1 or Melan-A Are Predictive for Survival of Patients With Distant Melanoma Metastasis

Journal of clinical oncology, 2012-05, Vol.30 (15), p.1835-1841

2012

Volltextzugriff (PDF)

Serum S100B, lactate dehydrogenase and brain metastasis are prognostic factors in patients with distant melanoma metastasis and systemic therapy

PloS one, 2013-11, Vol.8 (11), p.e81624-e81624

2013

Volltextzugriff (PDF)

Serum S100B and LDH at Baseline and During Therapy Predict the Outcome of Metastatic Melanoma Patients Treated with BRAF Inhibitors

Targeted oncology, 2021-03, Vol.16 (2), p.197-205

2021

Volltextzugriff (PDF)

Inhibition of PI3K-AKT-mTOR Signaling Sensitizes Melanoma Cells to Cisplatin and Temozolomide

Journal of investigative dermatology, 2009-06, Vol.129 (6), p.1500-1515

2009

Volltextzugriff (PDF)

Pimasertib Versus Dacarbazine in Patients With Unresectable NRAS-Mutated Cutaneous Melanoma: Phase II, Randomized, Controlled Trial with Crossover

Cancers, 2020-06, Vol.12 (7), p.1727

2020

Volltextzugriff (PDF)

Epidemiology of Skin Cancer: Update 2019

Sunlight, Vitamin D and Skin Cancer, p.123-139

Volltextzugriff (PDF)

Non-AIDS associated Kaposi's sarcoma: clinical features and treatment outcome

PloS one, 2011-04, Vol.6 (4), p.e18397-e18397

2011

Volltextzugriff (PDF)

Combined Inhibition of MAPK and mTOR Signaling Inhibits Growth, Induces Cell Death, and Abrogates Invasive Growth of Melanoma Cells

Journal of investigative dermatology, 2008-08, Vol.128 (8), p.2013-2023

2008

Volltextzugriff (PDF)

1 – 25 von 237

Suche als RSS-Feed

Aktive Filter

KollektionTaylor & Francis

KollektioneBooks on EBSCOhost

ThemaDermatology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(221)
Mit Volltextzugriff
(194)

Publikationsform

Artikel
(236)
Buchkapitel
(1)

Sprache

Englisch
(232)
Japanisch
(38)
Deutsch
(15)

Erscheinungsjahr

n.n

Thema

Science & Technology
(217)
Life Sciences & Biomedicine
(204)
Humans
(194)
Male
(112)
Female
(110)
Biological And Medical Sciences
(105)
Medical Sciences
(104)
Middle Aged
(86)
Tumors Of The Skin And Soft Tissue. Premalignant Lesions
(85)
Melanoma
(80)
Aged
(76)
Skin Neoplasms - Pathology
(73)
Oncology
(72)
Melanoma - Pathology
(71)
Adult
(68)
Prognosis
(43)
Tumors
(39)
Melanoma - Drug Therapy
(34)
Melanoma - Mortality
(34)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Partial Histological Tumor Regression in Primary Melanoma as Protective Factor for Lymph Node Micrometastasis

Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelines

Melanoma epidemiology and trends

Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma

European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics – Update 2019

Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

Phase II DeCOG-study of ipilimumab in pretreated and treatment-naïve patients with metastatic uveal melanoma

Phase III Randomized Clinical Trial Comparing Tremelimumab With Standard-of-Care Chemotherapy in Patients With Advanced Melanoma

Improving melanoma classification by integrating genetic and morphologic features

Final Results of Phase III SYMMETRY Study: Randomized, Double-Blind Trial of Elesclomol Plus Paclitaxel Versus Paclitaxel Alone As Treatment for Chemotherapy-Naive Patients With Advanced Melanoma

Results of a Phase III, Randomized, Placebo-Controlled Study of Sorafenib in Combination With Carboplatin and Paclitaxel As Second-Line Treatment in Patients With Unresectable Stage III or Stage IV Melanoma

Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients

β-Catenin signaling increases during melanoma progression and promotes tumor cell survival and chemoresistance

Real-world Treatment Patterns and Outcomes with Systemic Therapies in Unresectable Locally Advanced and Metastatic Cutaneous Squamous Cell Carcinoma in Germany

Peripheral PD-1+CD56+ T-cell frequencies correlate with outcome in stage IV melanoma under PD-1 blockade

Diagnostic Accuracy of Electrical Impedance Spectroscopy in Non-melanoma Skin Cancer

Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies

Functional T Cells Targeting NY-ESO-1 or Melan-A Are Predictive for Survival of Patients With Distant Melanoma Metastasis

Serum S100B, lactate dehydrogenase and brain metastasis are prognostic factors in patients with distant melanoma metastasis and systemic therapy

Serum S100B and LDH at Baseline and During Therapy Predict the Outcome of Metastatic Melanoma Patients Treated with BRAF Inhibitors

Inhibition of PI3K-AKT-mTOR Signaling Sensitizes Melanoma Cells to Cisplatin and Temozolomide

Pimasertib Versus Dacarbazine in Patients With Unresectable NRAS-Mutated Cutaneous Melanoma: Phase II, Randomized, Controlled Trial with Crossover

Epidemiology of Skin Cancer: Update 2019

Non-AIDS associated Kaposi's sarcoma: clinical features and treatment outcome

Combined Inhibition of MAPK and mTOR Signaling Inhibits Growth, Induces Cell Death, and Abrogates Invasive Growth of Melanoma Cells

Aktive Filter

Suchergebnisse filtern